Clinical Trials
3 trialsNCT07561723 2026-05-12
IMP3-saRNA Vaccine in Advanced NSCLC
West China Hospital
Phase 1 Recruiting
NCT01720836 2025-10-21
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
University of Pittsburgh
Phase 1/2 Recruiting
NCT00654030 2018-04-09
Allogeneic Cellular Vaccine 1650-G for Non-Small Cell Lung Cancer
University of Kentucky
Phase 2 Completed